Replies to post #287 on Vascular Biogenics Ltd (VBLT)

[davidal66]

In the four patients in the low dose cohort of 4 patients, the overall survival appears to be 6 months. So the mean os is 19 plus months in the therapeutic cohort and median os has not yet been reached but mean os is 19.9 months. This sounds excellent, but I'm not sure what mean os really means or how much this will be in sync with possible overall survival.

[gr8db8]

Lower dose level was not successful (0% vs 60% at therapeutic dose) -- current treatment is at 31%

I read the "median OS not reached" to mean that patients are still alive and that data will be better at ASCO.